Back to the feed
In brief
On 18.01.2024, a person holding the function "Executive member of the board of directors / senior management" at Santhera Pharmaceuticals Holding AG disclosed a purchase worth CHF 277’493 to SIX Exchange Regulation.
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open
Disclosure detail
A executive member of the board of directors / senior management of Santhera Pharmaceuticals Holding AG declared a "Purchase" transaction on 18.01.2024.
SIX publishes the manager's function, never their name: no individual is named in management transactions.
Transaction date18.01.2024
Issuing companySanthera Pharmaceuticals Holding AG
ISINCH1276028821
Transaction sidePurchase
Management functionExecutive member of the board of directors / senior management
Security typeRegistered shares
Quantity30’228
Unit priceCHF 9.18
AmountCHF 277’493
ExchangeXSWX
Notification IDT1O1I00026
Other Santhera Pharmaceuticals Holding AG insider transactions
These figures aggregate public disclosures. They are not investment advice.